| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Tennant Stanley is a Director at Cardiff Oncology, Inc.. Recent SEC Form 4 filings include 4 buys and 1 sell.
Estimated insider holdings value: $307K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 8, 2018 | CRDF Cardiff Oncology, Inc. | Director | Buy | 10,000 | $0.80 | $8,000.00 | +4.4% | |
| Sep 5, 2017 | CRDF Cardiff Oncology, Inc. | Director | Sell | 8,334 | $0.69 | $5,750.46 | -3.8% | |
| Dec 19, 2016 | CRDF Cardiff Oncology, Inc. | Director | Buy | 10,000 | $2.10 | $21,000.00 | +4.8% | |
| Dec 16, 2016 | CRDF Cardiff Oncology, Inc. | Director | Buy | 14,966 | $2.00 | $29,932.00 | +7.8% | |
| Aug 12, 2015 | CRDF Cardiff Oncology, Inc. | Director | Buy | 10,000 | $6.06 | $60,600.00 | +5.5% |